BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23702171)

  • 41. [Strategies for the Treatment of Community-Acquired Pneumonia in HIV-Positive Patients].
    Schleenvoigt BT; Rupp J; Rohde G; Rockstroh JK; Fätkenheuer G; Pletz MW
    Pneumologie; 2017 Apr; 71(4):207-214. PubMed ID: 28407674
    [No Abstract]   [Full Text] [Related]  

  • 42. Incidence and risk factors of bacterial pneumonia requiring hospitalization in HIV-infected patients started on a protease inhibitor-containing regimen.
    Le Moing V; Rabaud C; Journot V; Duval X; Cuzin L; Cassuto JP; Al Kaied F; Dellamonica P; Chêne G; Raffi F;
    HIV Med; 2006 May; 7(4):261-7. PubMed ID: 16630039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
    Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
    N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Acinetobacter baumannii community-acquired pneumonia in a patient with HIV infection].
    Mégarbane B; Bruneel F; Bédos JP; Wolff M; Régnier B
    Presse Med; 2000 Apr; 29(14):788-9. PubMed ID: 10816719
    [No Abstract]   [Full Text] [Related]  

  • 45. Etiology of pulmonary complications of human immunodeficiency virus-1-infected patients in Taiwan in the era of combination antiretroviral therapy: a prospective observational study.
    Lee KY; Ho CC; Ji DD; Lee CM; Tsai MS; Cheng AC; Chen PY; Tsai SY; Tseng YT; Sun HY; Lee YC; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2013 Dec; 46(6):433-40. PubMed ID: 23026388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microbiology of community-acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection. Implications for rational empiric antibiotic therapy.
    Burack JH; Hahn JA; Saint-Maurice D; Jacobson MA
    Arch Intern Med; 1994 Nov; 154(22):2589-96. PubMed ID: 7979856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced in vivo human immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia.
    Koziel H; Kim S; Reardon C; Li X; Garland R; Pinkston P; Kornfeld H
    Am J Respir Crit Care Med; 1999 Dec; 160(6):2048-55. PubMed ID: 10588627
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China.
    Zhang L; Huang Y; Liu Z; Liu W; Qin Q; Tao R
    J Med Virol; 2015 Jul; 87(7):1158-67. PubMed ID: 25777553
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nosocomial bacterial pneumonia in HIV-infected patients: risk factors for adverse outcome and implications for rational empiric antibiotic therapy.
    Franzetti F; Grassini A; Piazza M; Degl'innocenti M; Bandera A; Gazzola L; Marchetti G; Gori A
    Infection; 2006 Feb; 34(1):9-16. PubMed ID: 16501896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of respiratory disease.
    Tokman S; Huang L
    Clin Chest Med; 2013 Jun; 34(2):191-204. PubMed ID: 23702170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
    Ledergerber B; Mocroft A; Reiss P; Furrer H; Kirk O; Bickel M; Uberti-Foppa C; Pradier C; D'Arminio Monforte A; Schneider MM; Lundgren JD;
    N Engl J Med; 2001 Jan; 344(3):168-74. PubMed ID: 11188837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Streptococcus pneumoniae and Legionella pneumophila pneumonia in HIV-infected patients.
    Pedro-Botet ML; Sopena N; García-Cruz A; Mateu L; García-Núñez M; Rey-Joly C; Sabrià M
    Scand J Infect Dis; 2007; 39(2):122-8. PubMed ID: 17366028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiology of human immunodeficiency virus-associated pulmonary disease.
    Murray JF
    Clin Chest Med; 2013 Jun; 34(2):165-79. PubMed ID: 23702168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of community-acquired pneumonia in HIV-infected children.
    Gray D; Zar HJ
    Expert Rev Anti Infect Ther; 2009 May; 7(4):437-51. PubMed ID: 19400763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children.
    Madhi SA; Petersen K; Madhi A; Khoosal M; Klugman KP
    Clin Infect Dis; 2000 Jul; 31(1):170-6. PubMed ID: 10913417
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The incidence and etiology of community-acquired pneumonia in fever outpatients.
    Bao Z; Yuan X; Wang L; Sun Y; Dong X
    Exp Biol Med (Maywood); 2012 Nov; 237(11):1256-61. PubMed ID: 23239436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opportunistic infections: stemming the tide.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Apr; 3(4):42-7. PubMed ID: 11364202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection.
    Sullivan JH; Moore RD; Keruly JC; Chaisson RE
    Am J Respir Crit Care Med; 2000 Jul; 162(1):64-7. PubMed ID: 10903221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Etiology of community-acquired pneumonia in hospitalized patients in chile: the increasing prevalence of respiratory viruses among classic pathogens.
    Díaz A; Barria P; Niederman M; Restrepo MI; Dreyse J; Fuentes G; Couble B; Saldias F
    Chest; 2007 Mar; 131(3):779-787. PubMed ID: 17356093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.
    Furrer H; Egger M; Opravil M; Bernasconi E; Hirschel B; Battegay M; Telenti A; Vernazza PL; Rickenbach M; Flepp M; Malinverni R
    N Engl J Med; 1999 Apr; 340(17):1301-6. PubMed ID: 10219064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.